A California-based health-care company is seeing its shares bid up during Tuesday’s pre-market following an announcement that its subsidiary HearingAssist has launched its branded hearing products and related supplies on RiteAid.com, according to the release. This caused shares of Innerscope Hearing Technologies Inc. (OTCPK:INND) to face some significant buying pressure as we head towards the opening bell.
Innerscope Hearing is a manufacturer and a DTC distributor/retailer of FDA-registered hearing aids, personal sound amplifier products, hearing-related treatment therapies, doctor-formulated dietary hearing supplements, and proprietary CDB oil for treating tinnitus. It also owns and operates audiological and retail hearing device clinics and plans to continue to open and acquire additional clinics. The company operates five retail hearing device clinics in California.
At the time of writing, shares of this micro cap were bid at $0.0065/share (+4.84% implied open for sellers), which could insinuate that the recent support found to breakout of the multi-month downtrend might have some confirmation. It’ll be interesting to see how things play out at the open.
